McMaster University researchers have discovered a previously unknown cell-protecting function of a protein, which could open new avenues for treating age-related diseases and lead to healthier aging overall.
MPP signs on four generics makers to make Novartis’ Tasigna more accessible
The Medicines Patent Pool has set up sublicense agreements with four manufacturers to produce generic versions of Novartis’ cancer drug Tasigna, as part of an
June 23, 2023